Glucocorticoids (GCs) are essential therapeutic reagents for the treatment of lymphomas and leukemias. GCs cause cell death in certain types of lymphoid cells mediated by the process known as apoptosis. This cell death is completely inhibited by Bcl-2. Here we report that Bcl-2 and benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (zVADfmk), a broad spectrum caspase inhibitor, prevent loss of mitochondrial membrane potential (DCm) and the production of reactive oxygen species (ROS) caused by GC, while acetylAsp-Glu-Val-Asp-aldehyde (Ac-DEVD-CHO), an inhibitor of the caspase-3 family proteases, does not. This suggests that the inhibition by Bcl-2 and activation of some initiator caspases are upstream events of mitochondrial damage, whereas the activation of caspase-3 family proteases occurs downstream of mitochondrial changes. We also demonstrate that caspase-6 but not caspase-3 is cleaved and activated during GC-mediated apoptosis and that poly(ADP-ribose) polymerase (PARP), a substrate of caspases, also undergoes proteolysis. In addition, we provide the evidence that DNA fragmentation is markedly inhibited by Ac-DEVD-CHO, while cell death, assessed by the damage of the plasma membrane, is marginally inhibited or merely delayed.
Introduction
Programmed cell death also called apoptosis is an essential mechanism to remove superfluous or damaged cells during the development and maintenance of multicellular organisms. It is also well-known that chemotherapeutic drugs including glucocorticoids (GCs) kill tumor cells through an apoptotic mechanism. The Bcl-2 and caspase families of proteins have been identified as regulators and effectors of apoptosis, respectively. We previously reported that overexpression of Bcl-2 in leukemic cells completely inhibits GC-induced apoptosis and relieves the transrepressive function of glucocorticoid receptor (Miyashita and Reed, 1993; Miyashita et al, 1997) . However, the precise mechanism of how GC mediates apoptosis is yet to be elucidated.
Recently mitochondrial damage, observed as a disruption of the mitochondrial transmembrane potential (DCm) or an increase in reactive oxygen species (ROS) generation has been recognized as a cell death commitment step in the course of apoptosis induced by many stimuli. In recent years, evidence has accumulated that these mitochondrial alterations involve opening of the so-called permeability transition (PT) pore .
The ICE-like cysteine proteases or caspases play important roles in apoptosis. To date, more than ten family members have been identified and classified into two groups, initiators and effectors . Caspase-3 (Yama/CPP32/apopain) (Tewari et al, 1995; Fernandes-Alnemri et al, 1994; Nicholson et al, 1995) , one of the effector caspases, has been studied extensively using specific antibodies, inhibitors and fluorogenic substrates. Caspase-3-like proteases are activated during most apoptotic processes. Caspases are synthesized as zymogens and become activated by proteolytic processing at specific aspartic acid residues, resulting typically in the removal of an N-terminal prodomain and another cleavage event which produces the large and small subunits that comprise the active heterotetrameric protease. This processing and activation of caspases can be mediated either by themselves or by other caspases . The ability of caspases to cleave each other has suggested the existence of proteolytic cascades. However, the specific caspases involved and their relative order appears to vary widely depending on the cellular background and apoptotic stimulus.
Here we demonstrate the sequence of events that occur in GC-mediated apoptosis of a pre B-cell leukemia cell line and provide new insights into caspase cascades.
Results
Bcl-2 inhibits GC-induced loss of DCm and generation of reactive oxygen species
To determine whether Bcl-2 exerts its anti-apoptotic activity upstream or downstream of mitochondrial changes associated with GC-induced apoptosis, we overexpressed Bcl-2 in the human pre-B leukemia cell line 697 which is highly sensitive to GC. Previously reports indicated that Bcl-2 can completely inhibit GC-mediated cell death of 697 cells (Miyashita and Reed, 1993) . We utilized the membrane potential-sensitive carbocyanine probe, 3, 3'-dihexyloxacarbocyanine iodide (DiOC 6 (3)) to detect DCm and 6-carboxy-2', 7'-dichlorodihydrofluorescein diacetate, di(acetoxymethyl ester) (DCFH-DA) to assess intracellular oxidation (Petit et al, 1990; Hockenbery et al, 1993) . DCFH-DA is oxidized to a fluorogenic dye by reactive oxygen species (ROS) in cells. As shown in Figure 1A , treatment of control transfected 697-Neo cells with the synthetic GC, dexamethasone (DEX), decreased the percentage of cells with intact DCm, whereas loss of DCm was completely inhibited in 697-Bcl-2 cells. Overexpression of Bcl-2 also completely inhibited DEX-induced ROS production. Note that ROS generation was slower than loss of DCm in DEX-treated 697-Neo cells ( Figure 1B ). ROS generation was not observed at 24 h, for example, whereas DCm loss was evident at 16 h after the DEX treatment.
zVAD-fmk but not Ac-DEVD-CHO prevents ROS production and loss of DCm
Since we previously demonstrated that caspase-3-like proteases were activated during GC-mediated apoptosis (Miyashita et al, 1997) , we further investigated the relationship between the caspase activation and mitochondrial changes. In contrast to Bcl-2 overexpression, inhibition of caspase-3-like proteases by acetyl-Asp-Glu-Val-Asp-aldehyde (Ac-DEVD-CHO) did not block the loss of DCm or ROS production ( Figure  2A and 2B). The addition of Ac-DEVD-CHO into the culture medium, however, completely inhibited the activation of caspase-3-like proteases in DEX-treated 697-Neo cells as determined by a fluorogenic assay for DEVD-cleaving proteases. The inhibition was as efficient as that achieved by the overexpression of Bcl-2 ( Figure 2C ). Thus, the intracellular concentration of Ac-DEVD-CHO is high enough to prevent caspase-3 activation. In contrast, benzyloxycarbonyl-Val-AlaAsp(OMe)-fluoromethylketone (zVAD-fmk), a caspase inhibitor of broad specificity efficiently prevented the loss of DCm and ROS production (Figure 2A and 2B). These results indicate that, unlike caspase-3-like proteases, some caspases inhibited by zVAD-fmk but not by Ac-DEVD-CHO are activated upstream of mitochondrial damages.
Caspase-3-like proteases other than caspase-3 itself is involved in GC-mediated apoptosis
We next examined if caspase-3 became activated during GCmediated apoptosis. A potential substrate of caspase-3, poly(ADP-ribose) polymerase (PARP), was indeed cleaved after treatment of 697-Neo cells with DEX. Again, Bcl-2 completely blocked PARP cleavage ( Figure 3A ). However, no cleavage of caspase-3 was detected by immunoblot analysis of DEX-treated 697-Neo cells or 697-Bcl-2 cells ( Figure 3B ). Processed form of caspase-3 was not visualized even after the longer exposure of an X-ray film. Since caspases are synthesized as zymogens and proteolytically activated, we concluded that caspase-3-like proteases other than caspase-3 itself is activated in GC-mediated apoptosis. The validity of our immunoblotting assay was supported by analysis of lysates from 697-Neo cells which had been induced to undergo etoposide-mediated apoptosis. Using the same anti-caspase-3 antibody, procaspase-3 was cleaved and processed into its active form after 6 h of treatment with etoposide ( Figure 3C ). 
Caspase-6 is activated during GC-mediated apoptosis
To explore which caspases are activated during GC-mediated apoptosis, we next analyzed the cleavage of caspase-6 (Mch2) (Fernandes-Alnemri et al, 1995a) and caspase-8 (FLICE/MACH/Mch5) (Muzio et al, 1996; Boldin et al, 1996; Fernandes-Alnemri et al, 1996) . We detected two isoforms of caspase-8, which have recently been reported as caspase-8/ a and caspase-8/b (Scaffidi et al, 1997) , in the 697 cells. Although caspase-8 has also been shown to cleave PARP in vitro (Muzio et al, 1996) , cleavage of caspase-8 was not detected in GC-treated 697 cells throughout the time period examined ( Figure 4A ). This same antibody did detect processed caspase-8 in anti-Fas treated Jurkat cells (not shown). In contrast, the levels of procaspase-6, one of the other effector caspases, gradually decreased following treatment of 697-Neo cells with DEX, accompanied by the detection of the processed form of caspase-6 after 24 h of the treatment ( Figure 4B , upper panels). The time course of procaspase-6 cleavage was almost identical with that of PARP. Cleavage of procaspase-6 was again inhibited by the overexpression of Bcl-2 ( Figure 4B , lower panels). To confirm the activation of caspase-6, we used caspase-6-specific substrate, acetyl-Val-Glu-Ile-Asp-methylcoumarylamide (Ac-VEID-MCA) (Hirata et al, 1998) , and performed fluorometric measurement of caspase-6 activities. In 697-Neo cells but not in 697-Bcl-2 cells, caspase-6 activities increased after the treatment with DEX showing the similar kinetics as immunoblot analysis ( Figure 4C ).
Inhibition of caspase-3-like proteases inhibits DNA fragmentation but not DEX-induced cell death
Previously, we have shown that Ac-DEVD-CHO only partially blocked DEX-induced cell death as determined by trypan blue dye exclusion (Miyashita et al, 1997) . In this study, we examined the effect of this caspase inhibitor on DNA fragmentation which is one of the hallmarks of apoptosis. As anticipated from the previous work, Ac-DEVD-CHO delayed the loss of membrane integrity but did not prevent cell death determined by monitoring the ability of cells to exclude propidium iodide (PI) ( Figure 5A ). In contrast, DNA fragmentation was markedly inhibited by Ac-DEVD-CHO. Even after 48 h of DEX treatment very little DNA fragmentation was observed in cells cultured with Ac-DEVD-CHO ( Figure 5B ). Marked inhibition of PARP cleavage in DEX-treated 697 cells again indicates that the permeability of Ac-DEVD-CHO is high enough to prevent intracellular activation of caspase-3-like proteases (compare Figure 5C with Figure 3A) . However, zVAD-fmk again significantly blocked both cell death and DNA fragmentation ( Figure 5A and data not shown). 
Discussion
The hallmarks of apoptosis such as chromatin condensation or nuclear and DNA fragmentation are reported to be preceded by alterations in mitochondria . We have confirmed the loss of DCm and production of ROS during GC-mediated apoptosis. DCm reduction was an earlier event than ROS generation which is in agreement with previous reports suggesting sequential reduction of DCm followed by generation of ROS (Zamzami et al, 1995) . However, in our system, detectable ROS generation was even later than DNA fragmentation or the loss of membrane integrity.
In our cellular system, zVAD markedly inhibited the loss of DCm and production of ROS mediated by GC. In contrast, Ac-DEVD-CHO, an inhibitor of the caspase-3 Figure 3 Absence of caspase-3 processing during GC-induced apoptosis. (A and B) 697-Neo cells or 697-Bcl-2 cells were treated with 10 77 M of DEX. At various time points, cells were harvested and cell lysates were subjected to SDS ± PAGE, transferred to nitrocellulose and probed with anti-PARP (A) or anti-caspase-3 (B) antibodies. (C) 697-Neo cells were treated with 70 mM of etoposide. At indicated time points, cell lysates were obtained and subjected to SDS ± PAGE, transferred to nitrocellulose and probed with anti-caspase-3 antibody. Arrows indicate full length PARP (p116), processed PARP (p85), procaspase-3 (p32), and processed caspase-3 (p20) family proteases, did not block mitochondrial alterations. Recent reports indicated that zVAD-fmk and Ac-YVAD-CHO, an inhibitor of the caspase-1 family proteases, prevent the loss of DCm in UVB-mediated and anti-Fas mediated apoptosis, respectively (Bossy-Wetzel et al, 1998; Susin et al, 1997) . Including these data as well as ours, initiator caspases which are inhibited by zVAD and Ac-YVAD-CHO, but not by Ac-DEVD-CHO may function upstream of mitochondrial damage.
Our observation of PARP cleavage without proteolysis of caspase-3 demonstrates the involvement of caspase-3-like proteases other than caspase-3 in the GC-mediated Figure 4 Activation of caspase-6 but not caspase-8 during GC-induced apoptosis. 697-Neo and 697-Bcl-2 cells were treated with 10 77 M of DEX. At various time points cells were harvested and cell lysates were subjected to SDS ± PAGE, transferred to nitrocellulose and probed with anti-caspase-8 (A) or anti-caspase-6 (B) antibodies. (C) Cytosolic extracts were prepared from 697-Neo cells (open circles) and 697-Bcl-2 cells (closed circles) which were grown with 10 77 M of DEX for various times. Caspase-6 activities in the lysates were determined using a fluorescent substrate Ac-VEID-MCA. One unit corresponds to the activity that cleaves 1 nmol of the substrate at 378C in 2 h. Arrows indicate caspase-8/a (p55), caspase-8/b (p53), procaspase-6 (p34), and processed caspase-6 (p10) apoptotic process. This is in agreement with the finding that GC-mediated apoptosis is not impaired in the thymocytes of the mice deficient in caspase-3 (Kuida et al, 1996) . Interestingly, the cleavage of PARP was still observed in thymocytes from caspase-3-deficient mice in the same situation. Furthermore, we showed the evidence that caspase-6 is proteolytically activated during GC-induced apoptosis. Since caspase-6 is reported to be another effector caspase in apoptotic cells (Faleiro et al, 1997) , it is probable that caspase-6 but not caspase-3 contributes to GC-induced apoptosis. Activation of caspase-6 was not restricted to a specific cell line because its proteolysis was also observed in T-cell leukemia line Jurkat treated with DEX (data not shown). However, since the substrate specificity of caspase-6 is distinct from that of caspase-3 (VEHD vs DEVD) (Thornberry et al, 1997) , it is still possible that other caspase-3-like proteases, such as caspase-7 (Mch3/ICE-LAP3/CMH-1) (Fernandes-Alnemri et al, 1995b; Duan et al, 1996; Lippke et al, 1996) or other unknown caspases, may play some role in apoptosis mediated by GC, including the cleavage of PARP. At least a role for caspase-8, which has been shown to cleave PARP in vitro (Muzio et al, 1996) , was excluded from our experiments.
Lastly, we demonstrated that a caspase-3 inhibitor, Ac-DEVD-CHO, efficiently inhibited DNA degradation to nucleosome-sized fragments, but merely delayed cell death as assessed by loss of plasma membrane integrity. In this regard, DNA fragmentation factor 45 (DFF45) and an inhibitor of caspase-activated deoxyribonuclease (ICAD) have been cloned recently (Liu et al, 1997; Enari et al, 1998) . Mouse ICAD can be a counterpart of human DFF45. Caspase-mediated cleavage of ICAD is necessary to release active caspase-activated deoxyribonuclease (CAD). We thus speculate that, without the cleavage of ICAD/DFF45 in the presence Ac-DEVD-CHO, DNA fragmentation is not observed, while non-apoptotic cell death still occurs. Interestingly, it has also been shown that nuclear apoptosis, such as chromatin condensation, induced by either etoposide or Bax was inhibited by Z-VAD-fmk, while necrotic cell death was not prevented (Hirsh et al, 1997; Xiang et al, 1996) .
Various types of apoptotic signals have been shown to converge on the activation of caspases. However, our findings suggest the existence of`private' cascade of caspase activation for each apoptotic stimulation.
Materials and Methods
Cells and culture conditions 697-Bcl-2 and 697-Neo lines are human pre-B leukemia 697 cells infected with recombinant Bcl-2 retrovirus and control retrovirus, respectively (Miyashita and Reed, 1993) . 697 cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 50 U/ml penicillin and 0.1 mg/ml streptomycin. For some experiments, caspase inhibitors, Ac-DEVD-CHO and zVAD-fmk (Peptide Institute, Inc., Osaka, Japan) were added to the medium.
Antibodies
Recombinant caspase-6 and caspase-8 proteins were produced in bacteria and purified as His6-tagged fusion proteins using Ni-chelation affinity chromatography as described (Zhou et al, 1997) . New Zealand white rabbits were immunized multiple times with 0.5 mg doses of these recombinant proteins, delivered by subcutaneous injections in 77 M of DEX in the presence of 100 mM of Ac-DEVD-CHO. At various time points cells were harvested and cell lysates were subjected to immunoblotting probed with anti-PARP antibody. Arrows indicate full length and processed PARP (p116 and p85, respectively) an aluminum-based adjuvant. The specificity of the resulting antisera for detection of caspase-6 or -8 was confirmed by immunoblot analysis of recombinant purified caspases, showing reactivity with the intended caspases but not with caspases-1, 3, 7 or 10. Anti-PARP monoclonal antibody and anti-caspase-3 monoclonal antibody were purchased from Biomol and Transduction Laboratories, respectively.
Cell viability and DNA fragmentation assays
Cell viability was determined by flow-cytometric analysis of cells stained with 50 mg/ml of PI using a Becton-Dickinson FACSort. For DNA fragmentation assays, cells were recovered from cultures at various time points of DEX treatment and 10 6 cells were analyzed by the gel-electrophoresis method described previously (Sorenson et al, 1990) .
Immunoblot analysis
Protein detection with Western blot was performed as described previously (Miyashita et al, 1994) . Briefly, 30 mg (90 mg for caspase-6 detection) of the lysate were loaded onto SDS ± PAGE gels. Resolved proteins were electrophoretically transferred to nitrocellulose membranes. Anti-PARP and anti-caspase-3 monoclonal antibodies and anticaspase-6 and anti-caspase-8 polyclonal antibodies were used for primary antibodies. Horse radish peroxidase-conjugated goat anti-rabbit IgG (Sigma) and rabbit anti-mouse IgG (DAKO) were used as secondary antibodies, and proteins were visualized by ECL (Amersham).
Detection of mitochondrial membrane potential (DCm)
To detect DCm, DiOC 6 (3) (Molecular Probes) (dissolved in dimethylsulfoxide (DMSO) at 4 mM) was added to the cells (5610 5 ) to make the final concentration of 40 nM. After 15 min of incubation in a CO 2 incubator at 378C, cells were centrifuged and resuspended in PBS. Stained cells (10 000) were analyzed by a FACSort. Fluorescent cells were excited using a 488 nm argon-ion laser. Green fluorescence was monitored through a 530/20 nm band pass filter.
Detection of ROS production
Cells (5610 5 ) were loaded with 5 mM DCFH-DA (Molecular Probes) (dissolved in DMSO at 10 mM) for 1 h at 378C in a CO 2 incubator. Cells were then centrifuged and resuspended in PBS. Stained cells (10 000) were analyzed by a FACSort under the condition described above. In cytofluorometry, forward and side scatters were gated on the population of normal sized lymphocytes.
Fluorometric measurement of proteolytic cleavage
The fluorometric cleavage activities of 697 lysates were measured as described previously except that Ac-VEID-MCA and Ac-DEVD-MCA (Peptide Institute, Inc., Osaka, Japan) were used as fluorogenic substrates (Miyashita et al, 1997) . The fluorescence of the cleaved substrate was determined using a spectrophotometer set at an excitation wavelength of 365 nm and an emission wavelength of 450 nm.
